Overview

Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim 1)

Status:
Completed
Trial end date:
2020-03-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine insulin sensitivity in individuals that are lean normal glucose tolerant subjects after consumption of a normal low fat diet and after a high fat diet and to explore the effects of high fat consumption on the intestinal microbiome, and metabolic endotoxemia.( Aim 1 of the protocol, a separate record is available for Aim 2)
Phase:
Phase 2
Details
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Collaborator:
American Diabetes Association
Treatments:
Sevelamer